Quels risques sont associés à une grossesse multiple ?
Les grossesses multiples augmentent le risque de complications pour la mère et les bébés.
Grossesse multipleGonadotrophine chorionique
#4
La gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?
Des fluctuations hormonales peuvent affecter l'humeur et provoquer de l'anxiété.
Santé mentaleGonadotrophine chorionique
#5
Quels sont les effets à long terme de la gonadotrophine chorionique ?
Les effets à long terme sont généralement rares, mais un suivi est recommandé.
Effets à long termeGonadotrophine chorionique
Facteurs de risque
5
#1
Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?
L'âge, le poids et des antécédents d'hyperstimulation augmentent ce risque.
Hyperstimulation ovarienneFacteurs de risque
#2
Comment l'âge influence-t-il la fertilité ?
L'âge avancé peut réduire la qualité des ovules et augmenter les risques de complications.
ÂgeFertilité
#3
Les antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?
Oui, des antécédents de troubles hormonaux peuvent affecter la réponse au traitement.
Antécédents médicauxGonadotrophine chorionique
#4
Quels comportements de santé peuvent affecter la fertilité ?
Le tabagisme, l'alcool et le stress peuvent nuire à la fertilité et à la réponse hormonale.
Comportements de santéFertilité
#5
Y a-t-il des facteurs environnementaux qui influencent la fertilité ?
Oui, l'exposition à des toxines environnementales peut affecter la fertilité.
Facteurs environnementauxFertilité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gonadotrophine chorionique : Questions médicales les plus fréquentes",
"headline": "Gonadotrophine chorionique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gonadotrophine chorionique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-18",
"dateModified": "2025-03-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gonadotrophine chorionique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de la grossesse",
"url": "https://questionsmedicales.fr/mesh/D011257",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de la grossesse",
"code": {
"@type": "MedicalCode",
"code": "D011257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.780"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Gonadotrophine chorionique",
"alternateName": "Chorionic Gonadotropin",
"code": {
"@type": "MedicalCode",
"code": "D006063",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hirokazu Usui",
"url": "https://questionsmedicales.fr/author/Hirokazu%20Usui",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Reproductive Medicine, Chiba University Graduate School of Medicine, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Asuka Sato",
"url": "https://questionsmedicales.fr/author/Asuka%20Sato",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Eri Katayama",
"url": "https://questionsmedicales.fr/author/Eri%20Katayama",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Natsuko Nakamura",
"url": "https://questionsmedicales.fr/author/Natsuko%20Nakamura",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Kaori Koga",
"url": "https://questionsmedicales.fr/author/Kaori%20Koga",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Reproductive Medicine, Chiba University Graduate School of Medicine, Chiba, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Assessment of Mobile Health Applications for Management of Knee and/or Hip Osteoarthritis Using the Mobile Application Rating Scale.",
"datePublished": "2022-10-18",
"url": "https://questionsmedicales.fr/article/36256541",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RHU.0000000000001896"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patient-targeted mobile applications in healthcare.",
"datePublished": "2023-07-31",
"url": "https://questionsmedicales.fr/article/37646550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12968/hmed.2023.0158"
}
},
{
"@type": "ScholarlyArticle",
"name": "Usage of Mobile Applications or Mobile Health Technology to Improve Diet Quality in Adults.",
"datePublished": "2022-06-12",
"url": "https://questionsmedicales.fr/article/35745167",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu14122437"
}
},
{
"@type": "ScholarlyArticle",
"name": "mSexHealth: An Overview of Mobile Sexual Health Applications.",
"datePublished": "2022-06-02",
"url": "https://questionsmedicales.fr/article/35652779",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/0092623X.2022.2079576"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mobile applications in gastrointestinal surgery: a systematic review.",
"datePublished": "2023-04-04",
"url": "https://questionsmedicales.fr/article/37016081",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00464-023-10007-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de la grossesse",
"item": "https://questionsmedicales.fr/mesh/D011257"
},
{
"@type": "ListItem",
"position": 5,
"name": "Gonadotrophine chorionique",
"item": "https://questionsmedicales.fr/mesh/D006063"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gonadotrophine chorionique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gonadotrophine chorionique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gonadotrophine chorionique",
"description": "Comment se diagnostique une grossesse avec la gonadotrophine chorionique ?\nQuels niveaux de gonadotrophine indiquent une grossesse normale ?\nPeut-on utiliser la gonadotrophine chorionique pour diagnostiquer des tumeurs ?\nQuels tests sont utilisés pour mesurer la gonadotrophine chorionique ?\nQuand doit-on mesurer la gonadotrophine chorionique après la conception ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Mobile+Applications#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gonadotrophine chorionique",
"description": "Quels symptômes indiquent une grossesse précoce ?\nLa gonadotrophine chorionique cause-t-elle des effets secondaires ?\nQuels signes peuvent indiquer une grossesse extra-utérine ?\nComment la gonadotrophine chorionique affecte-t-elle l'humeur ?\nQuels symptômes peuvent indiquer une hyperstimulation ovarienne ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Mobile+Applications#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gonadotrophine chorionique",
"description": "Peut-on prévenir les complications liées à la gonadotrophine chorionique ?\nComment réduire le risque de grossesse extra-utérine ?\nY a-t-il des mesures préventives pour l'hyperstimulation ovarienne ?\nComment le mode de vie influence-t-il la fertilité ?\nLes femmes doivent-elles se faire dépister avant un traitement de fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Mobile+Applications#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gonadotrophine chorionique",
"description": "Comment la gonadotrophine chorionique est-elle utilisée en fertilité ?\nQuels sont les traitements pour les niveaux anormaux de gonadotrophine ?\nLa gonadotrophine chorionique est-elle utilisée pour traiter des tumeurs ?\nQuels médicaments contiennent de la gonadotrophine chorionique ?\nComment la gonadotrophine chorionique est-elle administrée ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Mobile+Applications#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gonadotrophine chorionique",
"description": "Quelles sont les complications possibles de la gonadotrophine chorionique ?\nComment l'hyperstimulation ovarienne se manifeste-t-elle ?\nQuels risques sont associés à une grossesse multiple ?\nLa gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?\nQuels sont les effets à long terme de la gonadotrophine chorionique ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Mobile+Applications#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gonadotrophine chorionique",
"description": "Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?\nComment l'âge influence-t-il la fertilité ?\nLes antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?\nQuels comportements de santé peuvent affecter la fertilité ?\nY a-t-il des facteurs environnementaux qui influencent la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Mobile+Applications#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment se diagnostique une grossesse avec la gonadotrophine chorionique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin ou urinaire détecte la présence de la gonadotrophine chorionique."
}
},
{
"@type": "Question",
"name": "Quels niveaux de gonadotrophine indiquent une grossesse normale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux de 5 à 426 mUI/ml sont typiques au début de la grossesse."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la gonadotrophine chorionique pour diagnostiquer des tumeurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent indiquer des tumeurs germinales ou trophoblastiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer la gonadotrophine chorionique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests immunologiques, comme les tests ELISA, sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quand doit-on mesurer la gonadotrophine chorionique après la conception ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle doit être mesurée environ 1 à 2 semaines après la conception."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une grossesse précoce ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des seins sensibles et des retards de règles."
}
},
{
"@type": "Question",
"name": "La gonadotrophine chorionique cause-t-elle des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des nausées et des vomissements chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Quels signes peuvent indiquer une grossesse extra-utérine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs abdominales sévères et saignements peuvent signaler une grossesse extra-utérine."
}
},
{
"@type": "Question",
"name": "Comment la gonadotrophine chorionique affecte-t-elle l'humeur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des fluctuations hormonales peuvent entraîner des changements d'humeur chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une hyperstimulation ovarienne ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ballonnements, douleurs abdominales et prise de poids rapide peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les complications liées à la gonadotrophine chorionique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des tests précoces peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de grossesse extra-utérine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical et une gestion des facteurs de risque peuvent réduire ce risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour l'hyperstimulation ovarienne ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance attentive lors des traitements de fertilité peut prévenir l'hyperstimulation."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il la fertilité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, y compris une alimentation équilibrée, peut améliorer la fertilité."
}
},
{
"@type": "Question",
"name": "Les femmes doivent-elles se faire dépister avant un traitement de fertilité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un dépistage complet est recommandé pour identifier les problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Comment la gonadotrophine chorionique est-elle utilisée en fertilité ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est administrée pour induire l'ovulation et soutenir la grossesse."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour les niveaux anormaux de gonadotrophine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, comme des médicaments ou une chirurgie."
}
},
{
"@type": "Question",
"name": "La gonadotrophine chorionique est-elle utilisée pour traiter des tumeurs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être utilisée dans le traitement de certains types de tumeurs germinales."
}
},
{
"@type": "Question",
"name": "Quels médicaments contiennent de la gonadotrophine chorionique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme l'HCG sont utilisés pour la fertilité et le traitement hormonal."
}
},
{
"@type": "Question",
"name": "Comment la gonadotrophine chorionique est-elle administrée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement administrée par injection intramusculaire ou sous-cutanée."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la gonadotrophine chorionique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'hyperstimulation ovarienne et les grossesses multiples."
}
},
{
"@type": "Question",
"name": "Comment l'hyperstimulation ovarienne se manifeste-t-elle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs abdominales, des nausées et un gonflement abdominal."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à une grossesse multiple ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les grossesses multiples augmentent le risque de complications pour la mère et les bébés."
}
},
{
"@type": "Question",
"name": "La gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des fluctuations hormonales peuvent affecter l'humeur et provoquer de l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme de la gonadotrophine chorionique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme sont généralement rares, mais un suivi est recommandé."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le poids et des antécédents d'hyperstimulation augmentent ce risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il la fertilité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé peut réduire la qualité des ovules et augmenter les risques de complications."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles hormonaux peuvent affecter la réponse au traitement."
}
},
{
"@type": "Question",
"name": "Quels comportements de santé peuvent affecter la fertilité ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'alcool et le stress peuvent nuire à la fertilité et à la réponse hormonale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux qui influencent la fertilité ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut affecter la fertilité."
}
}
]
}
]
}
Laboratory of Physiopathology and PharmacoToxicology of the Human Placenta, UMR-S 1139 Inserm - University Paris Descartes, Sorbonne Paris Cité, Paris, France.
Animal Biotechnology, Graduate School of Future Convergence Technology, Institute of Genetic Engineering, Hankyong National University, Ansung, 17579, Korea.
Animal Biotechnology, Graduate School of Future Convergence Technology, Institute of Genetic Engineering, Hankyong National University, Ansung, 17579, Korea. ksmin@hknu.ac.kr.
School of Animal Life Biotechnology, Institute of Genetic Engineering, Hankyong National University, Ansung, 17579, Korea. ksmin@hknu.ac.kr.
Department of Surgery, Dentistry, Paediatrics and Gynaecology, Paediatric Fertility Lab, Woman and Child Hospital, Division of Pediatric Surgery, University of Verona, 37134 Verona, Italy.
Department of Obstetrics and Gynaecology, Reproductive Endocrinology and Infertility Unit, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Obstetrics and Gynaecology, Reproductive Endocrinology and Infertility Unit, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Obstetrics and Gynaecology, Reproductive Endocrinology and Infertility Unit, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Mobile health applications (apps) can help individuals with knee and/or hip osteoarthritis (OA) learn about, monitor, and manage their condition. These apps have not been formally evaluated....
The aim of this study was to evaluate the publicly available mobile health apps for individuals with knee and/or hip OA using a systematic review....
We searched the Apple App Store, Android Google Play, and Amazon Appstore using the terms "arthritis," "osteoarthritis," "hip OA," "knee OA," "hip," "knee," "rehabilitation," "rehab," and "physical th...
Among 1104 identified apps, 94 met the inclusion/exclusion criteria for MARS appraisal. Fourteen apps met the predetermined score thresholds for final summary. Of the 14 apps appraised, the total over...
The majority of the apps we identified for knee and/or hip OA did not meet predetermined score thresholds for final summary. Many failed to provide comprehensive education and deliver management plans...
There has been an increase in the number of healthcare-related applications targeted at patients for use on mobile phones. With an increasing proportion of the population using such applications, it i...
The use of mobile applications for dietary purposes has dramatically increased along with the consistent development of mobile technology. Assessing diet quality as a dietary pattern or an indicator a...
The aim of this study was to examine the existing mobile applications focused on sexual health and analyze the included content and therapeutic techniques. Three databases with mobile applications wer...
Mobile applications can facilitate or improve gastrointestinal surgical care by benefiting patients, healthcare providers, or both. The extent to which applications are currently in use in gastrointes...
The PubMed, EMBASE and Cochrane databases were searched for articles up to October 6th 2022. Articles were considered eligible if they assessed or described mobile applications used in a gastrointesti...
Thirty-eight articles describing twenty-nine applications were included. The applications were classified into seven categories: monitoring, weight loss, postoperative recovery, education, communicati...
The interest for applications and their use in gastrointestinal surgery is increasing. From our study, it appears that most studies using applications fail to report adequate clinical evaluation, and ...
Colorectal cancer (CRC) is the third leading cause of cancer and the second cause of cancer-related deaths in the world. Despite the infrastructure and the availability of organized screening programs...
The present research was conducted in two phases: software design and evaluation. In the first phase, the software was prepared using the cascade method. First, all the educational content related to ...
In the software evaluation phase, the application was used by 204 users. In this stage, 84 (41.2%) women and 120 (58.8%) men, with an average (Standard Deviation) age of 47.53 (13.68) participated. Pa...
The results of the research indicated the positive impact of the Colon Cancer Application on the abilities of the users of self-assessment of colon cancer. Therefore, based on the findings, it can be ...
This study was registered in the Iranian Registry of Clinical Trials ( https://irct.behdasht.gov.ir ) on 13/2/2024, with the IRCT ID: IRCT20210131050189N9....
Mobile applications (apps) are multiplying in laryngology, with little standardization of content, functionality, or accessibility. The purpose of this study is to evaluate the quality, functionality,...
Of the 3230 apps identified from the Apple and Google Play stores, 28 patient-facing apps met inclusion criteria. Apps were evaluated using validated scales assessing quality and functionality: the Mo...
Twenty-six apps (92%) had adequate quality (MARS score > 3). The mean PEMAT score was 89% for actionability and 86% for understandability. On average, apps utilized 25/33 health literate strategies. T...
While most apps scored well in quality and functionality, many laryngology apps did not meet standards for health literacy. Most apps were written at a reading level above the national average, lacked...
The proliferation of mobile health (mHealth) applications is partly driven by the advancements in sensing and communication technologies, as well as the integration of artificial intelligence techniqu...
The goal of this scoping review is to gain an understanding of FL and its potential in dealing with sensitive and heterogeneous data in mHealth applications. Through this review, various stakeholders,...
We conducted a scoping review following the guidelines of PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews). We searched 7 commonly used dat...
A total of 1095 articles were retrieved during the database search, and 26 articles that met the inclusion criteria were included in the review. The analysis of these articles revealed 2 main applicat...
This scoping review has highlighted the potential of FL as a privacy-preserving approach in mHealth applications and identified the technical limitations associated with its use. The challenges and op...
Irritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder that represents a significant public health problem due to the impact it produces on quality of life. Recommended treat...
To develop a mobile health application (mHealth) accessible to deaf adolescents, based on their health card, promoting autonomy to the access to the user's health information....
This was a methodological study, divided into three stages: a questionnaire to understand the knowledge of deaf adolescents about the health card, and development of the application using videos in Br...
Most deaf adolescents were not aware of the health card. The application has two interface modes: male and female card, with the particularities of each sex. Furthermore, user's data security is carri...
The application provides information from the health card in text and video in Libras, according to the selected sex, promoting adolescents' autonomy in accessing health information. Future implementa...